Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06236724 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialAmended 20 times since 2024-01-24; most recent filed 2026-08-13. Every amendment is listed below.
Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.
| NCT Number | NCT06236724 |
| Lead Sponsor | M.D. Anderson Cancer Center
Collaborators: Novartis Pharmaceuticals |
| Conditions | Chronic Myeloid Leukemia |
| Enrollment | 50 participants |
| Start Date | 2024-01-31 |
| Primary Completion | 2033-07-01 (estimated) |
| Study Completion | 2035-07-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-14 |